CELU (Celularity Inc) Bozor qiymatining balans qiymatiga nisbati
Celularity Inc. (CELU) onkologiya va qarishga qarshi kurashishda yo'ldosh to'qimalaridan foydalanuvchi hujayralar terapiyasi sohasidagi kashfiyotchi sifatida tan olingan. Ushbu bozor qiymati grafigida ko'rsatilganidek, GURU.Markets platformasidagi kompaniyaning joriy bozor qiymati -0.63 ni tashkil etadi. Biznes o'zining saratonga qarshi liniyalari bo'yicha test natijalarini kutayotgan bir paytda ortopedik materiallar yetkazib berishga tayanadi. O'sish istiqbollari biobanklar va regenerativ texnologiyalarning joriy etilishi bilan bog'liq.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_CELU_-_Celularity-Inc._-_Market-Capitalization-to-Net-Assets "CELU Celularity Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 27.10.2026) | 👁️GURU.Markets👁️")
Celularity Inc. (CELU) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning dastlabki tahlili:Celularity Inc - CELU
Ushbu ko'rsatkich biznesning bozor qiymatini uning sof aktivlari bilan solishtirib, kapitalning haddan tashqari qimmat baholanganligi yoki past baholanganligi darajasini aniqlaydi. Ushbu koeffitsient kotirovkalar haqiqiy balans hisobotidan farq qilgan holda aksiyadorlar qiymatining yo'qolishi xavfini ko'rsatadi. Celularity Inc. (CELU) uchun bozor qiymatining kitob kapitaliga nisbati, naqd pulning yuqori sarf tezligi va hisobot shaffofligining pastligi sababli juda muhimdir. Ushbu egri chiziqni tahlil qilish biotexnologiya kompaniyasi boshqaruviga nisbatan bozor skeptitsizmini baholash imkonini beradi. Bu kapitalning haddan tashqari qimmat baholangan aktivlarda muzlab qolishining oldini olish uchun asosiy filtr vazifasini o'taydi.
Asosiy raqobatchilar
ARGX: Kapitallashuvning sof aktivlarga nisbati|BNTX (biontech.de) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Savara Inc SVRA|RIGL: Bozor kapitallashuvining balans qiymatiga nisbati|ANAB - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ATXS|ENGN (engene.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati RAPT Therapeutics|Bozor qiymatining balans qiymatiga nisbati Aerovate (JBIO)|Kapitallashuvning sof aktivlarga nisbati ACRS|Bozor kapitallashuvining balans qiymatiga nisbati KYTX (Kyverna Therapeutics, Inc)|Bozor qiymatining balans qiymatiga nisbati Tiziana Life Sciences TLSA|Bozor qiymatining balans qiymatiga nisbati cabalettabio.com CABA|Ventyx Biosciences, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|THTX: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Avalo Therapeutics Inc. AVTX|Eledon Pharmaceuticals, Inc (ELDN) - Balans qiymatiga nisbatan bozor qiymati|AGEN: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi climbbio.com (CLYM)|Kapitallashuvning sof aktivlarga nisbati Zura Bio|Bozor kapitallashuvining balans qiymatiga multiplikatori aTyr Pharma Inc ATYR|ADAG: Kapitallashuvning sof aktivlarga nisbati|IMA - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Shattuck Therapeutics (STTK)|EQ - Balans qiymatiga nisbatan bozor qiymati|connectbiopharm.com - Bozor kapitallashuvining balans qiymatiga nisbati|IMUX (Immunic) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Atara Biotherapeutics, Inc. (ATRA)|Kapitallashuvning balans qiymatiga nisbati InflaRx GmbH|Bozor kapitallashuvining balans qiymatiga nisbati XFOR (X4 Pharmaceuticals)|Kapitallashuvning sof aktivlarga nisbati adicetbio.com ACET|Kapitallashuvning sof aktivlarga nisbati INMB|Balans qiymatiga nisbatan bozor kapitallashuvi Barinthus Biotherapeutics PLC BRNS|KZR: Bozor kapitallashuvining balans qiymatiga nisbati|SABS - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati AKTX|ENLV (Enlivex Therapeutics Ltd.) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Q32 Bio Inc|Bozor qiymatining balans qiymatiga nisbati GeoVax Labs (GOVX)|Kapitallashuvning sof aktivlarga nisbati EDSA|Bozor kapitallashuvining balans qiymatiga nisbati IBIO (iBio Corporation)|Carisma Therapeutics Inc. (CARM) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi xtlbio.com XTLB|Bozor kapitallashuvining balans qiymatiga nisbati Bolt Bio (BOLT)|HCWB - Balans qiymatiga nisbatan bozor qiymati|APVO: Bozor kapitallashuvining balans qiymatiga nisbati|AIM (aimimmuno.com) - Bozor kapitallashuvining balans qiymatiga nisbati|ADTX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati GRI|Bozor qiymatining balans qiymatiga nisbati XRTX (XORTX Therapeutics)|Kapitallashuvning sof aktivlarga nisbati Vyome Holdings Inc. (HIND)|Bozor kapitallashuvining balans qiymatiga nisbati REVB (Revelation Bio)|INDP - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Scinai Immunotherapeutics (SCNI)|CALI - Balans qiymatiga nisbatan bozor qiymati|affimed.com - Bozor kapitallashuvining balans qiymatiga nisbati|ALLK (Allakos) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati HOOK|Kapitallashuvning sof aktivlarga nisbati IGMS|Bozor qiymatining balans qiymatiga nisbati ITOS (iTeos Therapeutics)|Kapitallashuvning sof aktivlarga nisbati oceanbiomedical.com OCEA|Kapitallashuvning sof aktivlarga nisbati TCBP (TC BioPharm)|Third Harmonic Bio Inc. - Bozor kapitallashuvining balans qiymatiga nisbati